{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:33Z","timestamp":1790975133280,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,18]]},"DOI":"10.1093\/cid\/cix1145","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T05:29:08Z","timestamp":1515130148000},"page":"18-24","source":"Crossref","is-referenced-by-count":60,"title":["Seroefficacy of Vi Polysaccharide\u2013Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV)"],"prefix":"10.1093","volume":"67","author":[{"given":"Merryn","family":"Voysey","sequence":"first","affiliation":[{"name":"Nuffield Department of Primary Care Health Sciences, University of Oxford, United Kingdom"},{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"key\n\t\t\t\t20180618193352_CIT0001","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.vaccine.2009.11.051","article-title":"Duration of Vi antibodies in participants vaccinated with Typhim Vi (Typhoid Vi polysaccharide vaccine) in an area not endemic for typhoid fever","volume":"28","author":"Froeschle","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180618193352_CIT0002","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10654-005-7454-6","article-title":"Outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast","volume":"20","author":"Michel","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"key\n\t\t\t\t20180618193352_CIT0003","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/21645515.2015.1117715","article-title":"Efficacy and safety of Vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph\u2122) in Indian children: school based cluster randomized study","volume":"12","author":"Mitra","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180618193352_CIT0004","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open- label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180618193352_CIT0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180618193352_CIT0006","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180618193352_CIT0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(08)70152-X","article-title":"Haemophilus influenzae type b conjugate vaccine use and effectiveness","volume":"8","author":"Morris","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180618193352_CIT0008","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial","volume":"362","author":"O\u2019Brien","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618193352_CIT0009","first-page":"CD001729","article-title":"Conjugate vaccines for preventing Haemophilus influenzae type b infections","volume":"4","author":"Swingler","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180618193352_CIT0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618193352_CIT0011","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"3","author":"Fraser","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180618193352_CIT0012","first-page":"CD001261","article-title":"Vaccines for preventing typhoid fever","volume":"1","author":"Anwar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180618193352_CIT0013","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0264-410X(03)00198-1","article-title":"Antigen dependent and independent mechanisms that sustain serum antibody levels","volume":"21(suppl 2)","author":"Traggiai","year":"2003","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180618193352_CIT0014","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.vaccine.2016.06.051","article-title":"The predicted persistence and kinetics of antibody decline 9years after pre-school booster vaccination in UK children","volume":"34","author":"Voysey","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180618193352_CIT0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v032.i06","article-title":"mixtools: An R package for analyzing finite mixture models","volume":"32","author":"Benaglia","year":"2009","journal-title":"J Stat Softw"},{"key":"key\n\t\t\t\t20180618193352_CIT0016","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20180618193352_CIT0017","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2011.11.108","article-title":"Production of a conjugate vaccine for Salmonella enterica serovar Typhi from Citrobacter Vi","volume":"30","author":"Micoli","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180618193352_CIT0018","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180618193352_CIT0019","author":"Typhoid Vaccine Acceleration Consortium (TyVAC)"},{"key":"key\n\t\t\t\t20180618193352_CIT0020","author":"World Health Organization","year":"2013"},{"key":"key\n\t\t\t\t20180618193352_CIT0021","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children","volume":"32","author":"Szu","year":"2014","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/1\/18\/25048078\/cix1145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T01:45:35Z","timestamp":1570585535000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/1\/18\/4815743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,17]]},"published-print":{"date-parts":[[2018,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix1145","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,1]]},"published":{"date-parts":[[2018,1,17]]}}}